The variant allele of the rs188140481 polymorphism confers a moderate increase in the risk of prostate cancer in Polish men

Eur J Cancer Prev. 2015 Mar;24(2):122-7. doi: 10.1097/CEJ.0000000000000079.

Abstract

A number of single nucleotide polymorphisms (SNPs) in the human genome have been associated with increased risk of prostate cancer. Recently, a single SNP in the region of chromosome 8q24 (rs188140481) has been associated with a three-fold increased risk of prostate cancer in Europe and North America. To establish whether rs188140481 is associated with the risk of prostate cancer in Poland, we genotyped 3467 men with prostate cancer and 1958 controls. The A allele of rs188140481 was detected in 44 of 3467 (1.3%) men with prostate cancer and in seven of 1958 (0.4%) controls (odds ratio=3.6; 95% confidence interval 1.6-7.9; P=0.0006). The allele was present in eight of 390 (2.1%) men with familial prostate cancer (odds ratio=5.8; 95% confidence interval 2.1-16.2; P=0.001). A positive family history of cancers at sites other than the prostate was observed in 27% of men who carried the rs188140481 risk allele and in 44% of noncarriers (P=0.04). No cancer at a site other than the prostate was more common in first-degree or second-degree relatives of carriers of the rs188140481 risk allele than relatives of noncarriers. The rs188140481 polymorphism in the 8q24 region confers a moderate increase in the risk of prostate cancer in Polish men. The SNP does not appear to be associated with susceptibility to cancers of other types.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Chromosomes, Human, Pair 8 / genetics*
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Genotype
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Pedigree
  • Poland
  • Polymorphism, Single Nucleotide
  • Prostatic Neoplasms / genetics*
  • White People / genetics*